Cryptomerone

Details

Top
Internal ID 1f4e999e-91e7-47ac-bf51-4d76cd69d345
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids
IUPAC Name (4S,5R)-4-hydroxy-5-(6-hydroxy-6-methylhept-1-en-2-yl)-2-methylcyclohex-2-en-1-one
SMILES (Canonical) CC1=CC(C(CC1=O)C(=C)CCCC(C)(C)O)O
SMILES (Isomeric) CC1=C[C@@H]([C@H](CC1=O)C(=C)CCCC(C)(C)O)O
InChI InChI=1S/C15H24O3/c1-10(6-5-7-15(3,4)18)12-9-13(16)11(2)8-14(12)17/h8,12,14,17-18H,1,5-7,9H2,2-4H3/t12-,14+/m1/s1
InChI Key LDDORMALZFELGA-OCCSQVGLSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H24O3
Molecular Weight 252.35 g/mol
Exact Mass 252.17254462 g/mol
Topological Polar Surface Area (TPSA) 57.50 Ų
XlogP 1.90
Atomic LogP (AlogP) 2.38
H-Bond Acceptor 3
H-Bond Donor 2
Rotatable Bonds 5

Synonyms

Top
24112-89-8

2D Structure

Top
2D Structure of Cryptomerone

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9943 99.43%
Caco-2 + 0.7032 70.32%
Blood Brain Barrier - 0.5000 50.00%
Human oral bioavailability + 0.5571 55.71%
Subcellular localzation Mitochondria 0.8286 82.86%
OATP2B1 inhibitior - 0.8549 85.49%
OATP1B1 inhibitior + 0.9029 90.29%
OATP1B3 inhibitior + 0.9469 94.69%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.5750 57.50%
BSEP inhibitior - 0.9362 93.62%
P-glycoprotein inhibitior - 0.9016 90.16%
P-glycoprotein substrate - 0.7253 72.53%
CYP3A4 substrate + 0.5089 50.89%
CYP2C9 substrate - 0.8060 80.60%
CYP2D6 substrate - 0.8734 87.34%
CYP3A4 inhibition - 0.6450 64.50%
CYP2C9 inhibition - 0.8250 82.50%
CYP2C19 inhibition - 0.8172 81.72%
CYP2D6 inhibition - 0.9224 92.24%
CYP1A2 inhibition - 0.9128 91.28%
CYP2C8 inhibition - 0.9084 90.84%
CYP inhibitory promiscuity - 0.8516 85.16%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.8928 89.28%
Carcinogenicity (trinary) Non-required 0.6538 65.38%
Eye corrosion - 0.9848 98.48%
Eye irritation - 0.5863 58.63%
Skin irritation + 0.5144 51.44%
Skin corrosion - 0.9712 97.12%
Ames mutagenesis - 0.9100 91.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5550 55.50%
Micronuclear - 0.9600 96.00%
Hepatotoxicity + 0.6750 67.50%
skin sensitisation + 0.7069 70.69%
Respiratory toxicity - 0.5222 52.22%
Reproductive toxicity + 0.6889 68.89%
Mitochondrial toxicity + 0.5625 56.25%
Nephrotoxicity - 0.5901 59.01%
Acute Oral Toxicity (c) III 0.7058 70.58%
Estrogen receptor binding - 0.7435 74.35%
Androgen receptor binding - 0.7665 76.65%
Thyroid receptor binding + 0.5577 55.77%
Glucocorticoid receptor binding + 0.5574 55.74%
Aromatase binding - 0.7233 72.33%
PPAR gamma - 0.5574 55.74%
Honey bee toxicity - 0.8699 86.99%
Biodegradation - 0.6000 60.00%
Crustacea aquatic toxicity - 0.5600 56.00%
Fish aquatic toxicity + 0.9918 99.18%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 94.85% 98.95%
CHEMBL253 P34972 Cannabinoid CB2 receptor 93.84% 97.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 92.49% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 91.32% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 90.21% 95.56%
CHEMBL2996 Q05655 Protein kinase C delta 86.32% 97.79%
CHEMBL3137262 O60341 LSD1/CoREST complex 84.22% 97.09%

Cross-Links

Top
PubChem 101297688
NPASS NPC44696